STTK
Shattuck Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.15
−5.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1922.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.45x
- Price / sales
- 516.87x
- Price / cash flow
- -12.60x
Enterprise value
- Enterprise value
- $456.2M
- EV / sales
- 456.25x
- EV / EBITDA
- -9.31x
- EV / EBIT
- -8.18x
- Market cap
- $516.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026